NASDAQ · Health care

Medicus Pharma Ltd. (MDCXW)

It posted a net loss of $56.7M. At June 30, 2026 it held $15.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Price

$0.36

0.00% on the day · September 22, 2026

52-week range $0.31 to $2.50

Market cap

$21.4M

What Medicus Pharma Ltd. does

Medicus Pharma Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MDCXW.

Revenue and profit by year

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	n/a	-$34.4M	-$47.3M	-$2.74	n/a
2024	n/a	-$11.2M	-$11.2M	-$1.16	n/a
2024	n/a	-$4.7M	-$5.3M	-$1.53	n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around October 21, 2026.

Estimated from its filing rhythm: about 70 days after its last report of August 12, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What Medicus Pharma Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 14, 2026
Activist stake (5% or more) SCHEDULE 13D
September 14, 2026
Securities offering prospectus 424B3
September 14, 2026
Material agreement ended 8-K
September 11, 2026
Unregistered share sale 8-K
September 3, 2026
Securities offering prospectus 424B3
September 3, 2026
Material agreement 8-K
August 13, 2026
Securities offering prospectus 424B3
August 12, 2026
Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.21 versus -$0.43.
June 4, 2026
Securities offering prospectus 424B3
June 4, 2026
Shareholder vote results 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 8, 2026. Insider transactions on SEC

Insider trades

What the people running Medicus Pharma Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 5 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)

last 90 days

Sold

last 90 days

Date	Insider	What	Shares	Price	Value	Filing
September 4, 2026	Bokhari RazaChief Executive Officer, Director	Received as pay	2,941,176	$0.17	$501.5K	Form 4
September 4, 2026	Bonner Carolyn F.President and CFO	Received as pay	1,470,588	$0.17	$250.7K	Form 4
September 4, 2026	Brennan Edward J.Chief Scientific Officer	Received as pay	588,235	$0.17	$100.3K	Form 4
September 4, 2026	Mehmud FaisalChief Medical Officer	Received as pay	1,470,588	$0.17	$250.7K	Form 4
September 4, 2026	Smith Andrew AlasdairChief Operating Officer	Received as pay	735,294	$0.17	$125.4K	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns MDCXW

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Melani Kenneth R.13G, passive with 1 related filers	18.2%	3,248,741	August 12, 2025
Bokhari, Raza13D, may seek influence with 1 related filers	5.3%	4,859,349	September 14, 2026

Latest filings below 5%: Raju Ajay 3.7% (May 5, 2026); Armistice Capital, LLC 4.99% (August 14, 2025); John Hathaway 4.5% (August 12, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

5 insiders reported holding 7,311,450 shares in total, about $2.6M at the last price.

Holder	Shares	As of
Bokhari RazaChief Executive Officer, Director	2,941,176	September 4, 2026
Bonner Carolyn F.President and CFO	1,489,493	September 4, 2026
Mehmud FaisalChief Medical Officer	1,470,588	September 4, 2026
Smith Andrew AlasdairChief Operating Officer	735,458	September 4, 2026
Brennan Edward J.Chief Scientific Officer	674,735	September 4, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about MDCXW

What does Medicus Pharma Ltd. do?

Medicus Pharma Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker MDCXW.

Is Medicus Pharma Ltd. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $56.7M.

When did Medicus Pharma Ltd. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake (5% or more) from September 14, 2026.

Similar companies

Compare MDCXW with

Compare MDCXW with any company

Follow MDCXW

Get an email when Medicus Pharma Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow MDCXW: get an email when it files

Where the numbers come from

Financial figures are the values Medicus Pharma Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.